Literature DB >> 8077941

Molecular cloning, sequencing and expression in Escherichia coli of the capsid protein gene from rabbit haemorrhagic disease virus (Spanish isolate AST/89).

J A Boga1, R Casais, M S Marin, J M Martin-Alonso, R S Carmenes, M Prieto, F Parra.   

Abstract

We describe the cloning, nucleotide sequencing and expression in Escherichia coli of the major capsid component (VP60) from the Spanish field isolate AST/89 of rabbit haemorrhagic disease virus (RHDV). The sequence of the 3'-terminal 2483 nucleotides of the genome was found to be 95.4% identical to the German RHDV strain, showing ten changes in the deduced VP60 amino acid sequence. The gene coding for this structural polypeptide has been expressed in bacteria as a beta-galactosidase fusion protein or using a T7 RNA polymerase-based system. The VP60 fusion protein showed only partial antigenic similarity with native VP60 and did not confer protective immunity. The recombinant VP60 produced in the T7 RNA polymerase-based system was antigenically similar to the viral polypeptide as determined using polyclonal and monoclonal antibodies. When used to immunize rabbits the recombinant VP60 was able to protect the animals against a lethal challenge using purified RHDV.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8077941     DOI: 10.1099/0022-1317-75-9-2409

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  18 in total

1.  Polymerase chain reaction amplification and gene sequence analysis of a calicivirus from a feral rabbit.

Authors:  K M Tham; S M Barnes; S N Hunter
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

2.  Horizontal transmissible protection against myxomatosis and rabbit hemorrhagic disease by using a recombinant myxoma virus.

Authors:  J Bárcena; M Morales; B Vázquez; J A Boga; F Parra; J Lucientes; A Pagès-Manté; J M Sánchez-Vizcaíno; R Blasco; J M Torres
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Microheterogeneity of p60 capsid protein and the encoding gene among contemporary isolates of rabbit hemorrhagic disease virus.

Authors:  E Viaplana; A Villaverde
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

4.  Protection against myxomatosis and rabbit viral hemorrhagic disease with recombinant myxoma viruses expressing rabbit hemorrhagic disease virus capsid protein.

Authors:  S Bertagnoli; J Gelfi; G Le Gall; E Boilletot; J F Vautherot; D Rasschaert; S Laurent; F Petit; C Boucraut-Baralon; A Milon
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

5.  Immunization with potato plants expressing VP60 protein protects against rabbit hemorrhagic disease virus.

Authors:  S Castañón; M S Marín; J M Martín-Alonso; J A Boga; R Casais; J M Humara; R J Ordás; F Parra
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

6.  Self-assembly, antigenicity, and immunogenicity of the rabbit haemorrhagic disease virus (Czechoslovakian strain V-351) capsid protein expressed in baculovirus.

Authors:  H S Nagesha; L F Wang; A D Hyatt; C J Morrissy; C Lenghaus; H A Westbury
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

7.  Oral immunization of rabbits with VP60 particles confers protection against rabbit hemorrhagic disease.

Authors:  J Plana-Duran; M Bastons; M J Rodriguez; I Climent; E Cortés; C Vela; I Casal
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

8.  Processing of rabbit hemorrhagic disease virus polyprotein.

Authors:  J M Martín Alonso; R Casais; J A Boga; F Parra
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

9.  Oral immunization using tuber extracts from transgenic potato plants expressing rabbit hemorrhagic disease virus capsid protein.

Authors:  José M Martín-Alonso; Sonia Castañón; Pablo Alonso; Francisco Parra; Ricardo Ordás
Journal:  Transgenic Res       Date:  2003-02       Impact factor: 2.788

10.  The efficacy of a bivalent vaccine against pasteurellosis and rabbit haemorrhagic disease virus.

Authors:  R Peshev; L Christova
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.